4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-020862
EVP, Growth Markets Commercial sold 457 shares at $17.89 ($8,177)
- EVP, Growth Markets Commercial acquired 872 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nazzi Gianfranco · EVP, Growth Markets Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-17 | Exercise or conversion : show line 1 in the form | +872 | 6,203.36 | D | ||
| 2018-03-19 | Sale : show line 2 in the form | −457 | $17.89 | $8,177 | 5,746.36 | D |
| Open-market sales · 457 sh · avg $17.89 · $8,177 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-17 | Exercise or conversion : show line 3 in the form Restricted Share Units | −872 | 1,746 | D |
Loading xslF345X03/doc4.xml…